Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Uyttenboogaart

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
European Journal of Neurology|December 18, 2018
Is there still a role for intravenous thrombolysis in the era of mechanical thrombectomy in patients with acute intracranial large artery occlusions?M Uyttenboogaart
European Journal of Neurology|November 20, 2009
Intravenous thrombolysis for patients with ischaemic stroke on antiplatelet therapy: a blessing in disguise?M Uyttenboogaart, G J Luijckx
Current Topics in Medicinal Chemistry|October 24, 2009
Thrombolysis for acute ischemic strokeM Uyttenboogaart, J De Keyser, G J Luijckx
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Factors associated with the risk of secondary progression in multiple sclerosisM Koch, M Uyttenboogaart, A van Harten, et al.
The Netherlands Journal of Medicine|November 17, 2009
A patient with neck pain and fever. Combined prevertebral and intraspinal abscess in a patient with a de novo HIV infectionE ter Avest, M Uyttenboogaart, J Dorgelo, et al.
European Journal of Neurology|June 4, 2009
Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional studyM Koch, J Mostert, M Heerings, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2009
Parity and secondary progression in multiple sclerosisM Koch, M Uyttenboogaart, D Heersema, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 22, 2010
Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic strokeI Miedema, M Uyttenboogaart, K Koopman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2008
Fatigue, depression and progression in multiple sclerosisM Koch, M Uyttenboogaart, A van Harten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2008
Utility of the stroke-thrombolytic predictive instrumentM Uyttenboogaart, R E Stewart, P C Vroomen, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
European Journal of Neurology|December 18, 2018
Is there still a role for intravenous thrombolysis in the era of mechanical thrombectomy in patients with acute intracranial large artery occlusions?M Uyttenboogaart
European Journal of Neurology|November 20, 2009
Intravenous thrombolysis for patients with ischaemic stroke on antiplatelet therapy: a blessing in disguise?M Uyttenboogaart, G J Luijckx
Current Topics in Medicinal Chemistry|October 24, 2009
Thrombolysis for acute ischemic strokeM Uyttenboogaart, J De Keyser, G J Luijckx
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Factors associated with the risk of secondary progression in multiple sclerosisM Koch, M Uyttenboogaart, A van Harten, et al.
The Netherlands Journal of Medicine|November 17, 2009
A patient with neck pain and fever. Combined prevertebral and intraspinal abscess in a patient with a de novo HIV infectionE ter Avest, M Uyttenboogaart, J Dorgelo, et al.
European Journal of Neurology|June 4, 2009
Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional studyM Koch, J Mostert, M Heerings, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 19, 2009
Parity and secondary progression in multiple sclerosisM Koch, M Uyttenboogaart, D Heersema, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 22, 2010
Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic strokeI Miedema, M Uyttenboogaart, K Koopman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 7, 2008
Fatigue, depression and progression in multiple sclerosisM Koch, M Uyttenboogaart, A van Harten, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 19, 2008
Utility of the stroke-thrombolytic predictive instrumentM Uyttenboogaart, R E Stewart, P C Vroomen, et al.
Pageof 3